ELAN
Elanco Animal Health, Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$22.42
−1.41%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$22.77
From 52W high−16.47%
Volume7.91M
Market cap$11.20B
P/E (TTM)—
P/S (TTM)2.2x
Div yield—
Key dataSep 18, 2026
Open
$22.77
From 52W high
−16.47%
Volume
7.91M
Market cap
$11.20B
ValuationView details →
P/E (Fwd)
18.8x
EV/EBITDA
18.8x
P/E (TTM)
—
RSI (14)
36.8
MomentumView details →
1D Return
−1.41%
YTD Return
−0.77%
SummaryUpdated Jun 1, 2026
Elanco Animal Health Incorporated (NYSE:ELAN) is a leading global animal health company that develops, manufactures, and markets products for both companion animals (pets) and farm animals. Founded in 1954 as a division of Eli Lilly and Company, Elanco operated as part of the pharmaceutical giant for over six decades before being spun off as an independent public company in September 2018. The company is headquartered in Greenfield, Indiana, and has established itself as one of the largest animal health companies worldwide, serving veterinarians, pet owners, and livestock producers across more than 90 countries.
Similar companies
Latest newsMore news →